Zhende Medical(SH:603301) Sou Hu Cai Jing·2025-12-26 00:37Core Viewpoint - The stock of Zhendemedical (603301) experienced a decline of 2.51% on December 25, 2025, closing at 71.8 yuan, with significant net inflows from major funds and outflows from retail investors [1][2]. Group 1: Stock Performance and Trading Data - On December 25, 2025, Zhendemedical's trading volume was 58,300 hands, with a total transaction amount of 419 million yuan [1]. - Major funds had a net inflow of 85.32 million yuan, accounting for 20.37% of the total transaction amount, while retail investors had a net outflow of 76.17 million yuan, representing 18.18% of the total [1][2]. - Over the past five days, the stock price fluctuated, with a high of 73.65 yuan on December 24, 2025, and a low of 67.55 yuan on December 19, 2025 [2]. Group 2: Financing and Margin Trading Data - On December 25, 2025, the financing balance was 1.372 billion yuan, with a net financing purchase of 63.66 million yuan [3]. - The margin trading data indicated a total of 1.49 million shares in margin trading, with a margin balance of 1.0698 million yuan [3]. Group 3: Company Financials and Industry Comparison - For the first three quarters of 2025, Zhendemedical reported a main business revenue of 3.184 billion yuan, a year-on-year increase of 1.88%, but a net profit of 203 million yuan, a decrease of 33.91% [5]. - The company's gross profit margin stood at 33.93%, significantly lower than the industry average of 51.02%, ranking 97th out of 125 in the industry [5]. - Zhendemedical's total market capitalization is 19.087 billion yuan, with a price-to-earnings ratio of 70.45, which is lower than the industry average of 81.69 [5].